Algorithm for recall of HIV reactive Indian blood donors by sequential immunoassays enables selective donor referral for counseling

Journal of Postgraduate Medicine

Volumn 52, Issue 2, 2006, Pages 106-109

  Thakral, B ^a   Saluja, K ^a   Sharma, R R ^a   Marwaha, N ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Biological false reactive; Donor Recall; ELISA; HIV; Rapid tests

Indexed keywords

ANTIGEN P24; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; PROTEIN P55;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALGORITHM; ANTIBODY SCREENING; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INTERMETHOD COMPARISON; MALE; NONHUMAN; NUCLEIC ACID ANALYSIS; PATIENT COUNSELING; PATIENT REFERRAL; SEROPREVALENCE; WESTERN BLOTTING;

ADULT; ALGORITHMS; BLOOD DONORS; BLOTTING, WESTERN; COUNSELING; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV SEROPREVALENCE; HIV-1; HUMANS; INDIA; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 33646589950     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Kleinman S, Busch MP, Hall L, Thomson R, Glynn S, Gallahan D, et al. False-positive HIV 1 test results in a low-risk screening setting of voluntary blood donation. Retrovirus Epidemiology Donor Study. JAMA 1998;280:1080-5.
2. Wartick MG, McCarroll DR, Wiltbank TB. A second discriminator for biological false positive results in enzyme-linked immunosorbent assays for antibodies to human immunodeficiency virus (HTLV-III/LAV). Transfusion 1987;27:109-11.
3. An Action Plan for Blood Safety. National AIDS Control Organization, Ministry of Health and Family Welfare, Government of India; 2003. p. 35-7.
4. st July 2004. Ministry of Health & Family Welfare, Government of India.
5. World Health Organization (WHO). Nutritional anemia: Report of a WHO Scientific Group. Technical Report Series No. 405, WHO: Geneva; 1968.
6. World Health Organization (WHO). Nutritional anemia: Report of a WHO Scientific Group. Technical Report Series No. 580, WHO: Geneva; 1975.
7. Gallo D, Diggs JL, Shell GR, Dailey PJ, Hoffman MN, Riggs JL. Comparison of detection of antibody to the acquired immune deficiency syndrome virus by enzyme immunoassay, immunofluorescence and western blot methods. J Clin Microbiol 1986;23:1049-51.
8. th ed. 2003. p. 279-303.
9. Busch MP. To thy (reactive) donors be true! Transfusion 1997;37:117-20.
10. st July 2004. Ministry of Health & Family Welfare, Government of India.
11. Makroo RN, Salil P, Vashist RP, Shivlal. Trends of HIV infection in blood donors of Delhi. Indian J Pathol Microbiol 1996;39:139-42.
12. Nanu A, Sharma SP, Chatterjee K, Joyti P. Markers for transfusion transmissible infections in north Indian voluntary and replacement blood donors: Prevalence and Trends 1989-96. Vox Sang 1997;73:70-3.
13. Choudhury N, Ayagiri A, Ray VL. True HIV Seroprevalence in Indian blood donors. Transfusion Med 2000;10:1-4.
14. Kapur S, Mittal A. Incidence of HIV infection and its predictors in blood donors in Delhi, India. J Med 1998;108:45-50.
15. Khurana SB, Ram S. Seroprevalence of blood donors and patients for HIV during 1988 to March 1997 at Ludhiana Punjab: HIV/AIDS research in India / editors Aggarwal OP, Sharma AK, Indrayan A: National AIDS Control Organization: New Delhi; 1998.p. 423-6.
16. Bhushan N, Pulimrod BR, Babu PG, John TJ. Rising trend in prevalence of HIV infection among blood donors. Indian J Med Res 1994;99:195-7.
17. Chatterjee R, Tarwater P, Neogi D, Ghosh A, Roy P, Sengupta S, et al. Estimation of HIV seroprevalence in blood bank camps in Kolkata, India. Transfusion Med 2004;14:77-8.
18. Kiely P, Stewart Y, Castro L. Analysis of voluntary blood donors with biologic false reactivity on chemiluminescent immunoassays and implications for donor management. Transfusion 2003;43:584-90.
19. Dufour DR, Talastas M, Fernandez MD, Harris B, Strader DB, Seeff LB. Low-positive Anti-Hepatitis C Virus Enzyme Immunoassay Results: An Important Predictor of Low Likelihood of Hepatitis C Infection. Clin Chem 2003;49:479-86.
20. Craske J, Turner A, Abbott R, Collier M, Gunson HH, Lee D, et al. Comparison of false positive reaction in direct binding anti HIV ELISA using cell lysate or recombinant antigens. Vox Sang 1990;59:160-6.
21. Guiltinan AM, Murphy EL, Horton JA, Nass CC, McEntire RL, Watanabe K. Psychological distress in blood donors notified of HTLV I/II infection. Retrovirus Epidemiology Donor Study. Transfusion 1998;38:1056-62.
22. Kleinman SH, Willams AE, Busch MP. Donor reactions to notification of abnormal test results (abstract). Transfusion 1999;39:113S.
23. Kiely P, Wood E. Can we improve the management of blood donors with nonspecific reactivity in viral screening and confirmatory assays? Transfusion Med Rev 2005;19:58-65.
24. Busch MP, Kleinman SH, Williams AE, Smith JW, Ownby HE, Laycock ME, et al. Frequency of human immunodeficiency virus (HIV) infection among contemporary anti HIV 1 and HIV 1/2 supplemental test - indeterminate blood donors. The Retrovirus Epidemiology Donor Study. Transfusion 1996;36:37-44.
25. Dodd RY, Stramer SL. Indeterminate results in blood donor testing: what you don't know can hurt you. Trans Med Rev 2000;14:151-60.
26. Celum CL, Coombs RW, Jones M, Murphy V, Fisher L, Grant C, et al. Risk factors for repeatedly reactive HIV 1 ELISA and indeterminate Western Blots: a population based case control study. Arch Intern Med 1994;154:1129-37.
27. Sharma UK, Stramer SL, Wright DJ, Glynn SA, Hermansen S, Schreiber GB, et al. Impact of changes in viral marker screening assays. Transfusion 2003;43:202-14.
28. Seed CR, Margaritis AR, Bolton WV, Kiely P, Parker S, Piscitelli L. Virology Subcommittee of the National Donor and Product Safety Committee, Australian Red Cross Blood Service. Improved efficiency of national HIV, HCV and HTLV antibody testing algorithm based on sequential screening immunoassays. Transfusion 2003;43:226-34.
29. Chattopadhya D, Aggarwal RK, Baveja UK, Doda V, Kumari S. Evaluation of epidemiological and serological predictors of human immunodeficiency virus type 1 (HIV 1) infection among high risk professional blood donors with western blot indeterminate results. J Clin Virol 1998;11:39-49.
30. Dock NL, Kleinman SH, Rayfield MA, Schable CA, Williams AE, Dodd RY. Human immunodeficiency virus infection and indeterminate western blot patterns. Prospective studies in a low prevalence population. Arch Intern Med 1991;151:525-30.
31. Busch MP, Glynn SA, Wright DJ, Hirschkorn D, Laycock ME, McAuley J, et al. National Heart, Lung, Blood Institute Nucleic Acid Test Study Group. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection. Transfusion 2005;45:1853-63.
32. Koppelman MH, Assal A, Chudy M, Torres P, de Villaescusa RG, Reesink HW, et al. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA and hepatitis B virus DNA in blood donations. Transfusion 2005;45:1258-66.
33. Canna F, Trevino E, Dominguez C, Gastaldello R, Barbas G, Cudola A, et al. Screening of HIV in blood banks. Evaluation of fourth generation kits. Medicina (B Aires) 2003;63:685-91.
34. Weber B, Gurtler L, Thorstensson R, Michl U, Muhlbacher A, Burgisser P, et al. Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity. J Clin Microbiol 2002;40:1938-46.